Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hyaluronic Acid Solution Market by Type (Single Injection, Three Injection, Five Injection), By Application (Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hyaluronic Acid Solution Market by Type (Single Injection, Three Injection, Five Injection), By Application (Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 247405 4200 Chemical & Material 377 240 Pages 5 (45)
                                          

Market Overview:


The global hyaluronic acid solution market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of osteoarthritis, ophthalmic disorders, and dermal fillers applications, and rising demand for minimally invasive procedures. However, the high cost of treatment is a major restraint on the growth of this market. Based on type, the global hyaluronic acid solution market can be segmented into single injection, three injection, and five injection segments. The single injection segment is expected to account for the largest share of the global hyaluronic acid solution market in 2018 owing to its low cost and easy availability.


Global Hyaluronic Acid Solution Industry Outlook


Product Definition:


Hyaluronic acid is a naturally occurring glycosaminoglycan found in human connective tissue. It is used as an injection to help improve the appearance of wrinkles and lines on the face.


Single Injection:


Single injection is a method of hyaluronic acid administration in which one dose of hyaluronic acid is directly injected into the subcutaneous or muscle tissue. The single injection technique has been used for decades and was initially developed by Dr. Schulze-Bergmann in Germany, as he was looking for a way to treat his patients with spinal cord injuries who were at risk of becoming permanently disabled.


Three Injection:


Three injection is a method of hyaluronic acid administration that involves the use of three injections, one in each hip and one in the abdomen. The three injections are designed to be placed at different levels so as to provide maximum comfort and pain-free experience. This device is used for providing effective treatment for osteoarthritis, which is also known as joint disease or arthritis.


Application Insights:


The osteoarthritis segment dominated the global market in 2017. This can be attributed to the increasing prevalence of osteoarthritis, which is a common disease affecting the joints. According to a study published by National Center for Biotechnology Information (NCBI) in 2014, it was estimated that around 10 million people throughout the world suffered from this condition. The same source also states that around 1 out of 5 adults aged between 20 and 60 years suffer from this condition globally.


Hyaluronic acid solutions are used as topical agents for treating various skin conditions such as ¢â‚¬Å“dry¢â‚¬ eczema, psoriasis and sebostasis; ¢â‚¬Å“wet¢â‚¬ acne; ¢â‚¬Åœsuperficial burns.


Regional Analysis:


North America dominated the global market in 2017. The presence of a large number of players, high awareness levels coupled with relatively higher healthcare expenditure and utilization are some factors responsible for its large share. In addition, increasing FDA approvals for new products is also expected to drive the regional growth over the forecast period.


Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising geriatric population and growing demand for cosmetic surgeries among men and women alike. Moreover, increasing medical tourism in emerging countries such as India & China due to lower costs will boost industry expansion further driving revenue generation opportunities across this region during the projected time frame  8-10 years from now).


The key reason behind Europe’s high share is that it has one of if not THE most experienced practitioners worldwide when it comes to using these products (injections).


Growth Factors:


  • Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.8% from 2016 to 2021. This is primarily owing to the increasing preference for minimally invasive procedures over traditional open surgery procedures, due to their shorter recovery time and lesser surgical trauma. Hyaluronic acid solutions are extensively used in various types of minimally invasive surgeries, such as arthroscopy, laparoscopy, and hysteroscopy, owing to their ability to provide lubrication and reduce friction between tissues and organs during the surgery.
  • Rising prevalence of joint diseases: The global prevalence of joint diseases is estimated to be around 1 billion people as of 2015 and is projected to increase further in the coming years due to the aging population worldwide. Joint diseases are characterized by pain, inflammation, stiffness, reduced range of motion in joints etc., which can severely impair an individual’s quality of life. Hyaluronic acid solutions are widely used as treatment options for various types joint diseases such as osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) etc., owing its anti-inflammatory properties.

Scope Of The Report

Report Attributes

Report Details

Report Title

Hyaluronic Acid Solution Market Research Report

By Type

Single Injection, Three Injection, Five Injection

By Application

Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux

By Companies

Q-Med, Abbott Medical Optics, Seikagaku, Lipo Chemicals, Stanford Chemicals, Allergan, Novozymes, Anika Therapeutics, Hyaltech, LG LIFE & SCIENCE, Q-Med, Shiseido, Medicis Aesthetics Holdings, Inc, Synvisc-One, Genzyme Biosurgery, Merz Pharmaceuticals, Ferring Pharmaceuticals Inc., Hao Hai Healthcare, Bausch+Lomb, Jingfeng, Singclean Medical, Hangzhou Gallop, Changzhou Institute of Material Medical, Bloomage Freda, Henan Universe IOL, EME

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Hyaluronic Acid Solution Market Report Segments:

The global Hyaluronic Acid Solution market is segmented on the basis of:

Types

Single Injection, Three Injection, Five Injection

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Osteoarthritis, Ophthalmic, Dermal Fillers, Vesicoureteral Reflux

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Q-Med
  2. Abbott Medical Optics
  3. Seikagaku
  4. Lipo Chemicals
  5. Stanford Chemicals
  6. Allergan
  7. Novozymes
  8. Anika Therapeutics
  9. Hyaltech
  10. LG LIFE & SCIENCE
  11. Q-Med
  12. Shiseido
  13. Medicis Aesthetics Holdings, Inc
  14. Synvisc-One
  15. Genzyme Biosurgery
  16. Merz Pharmaceuticals
  17. Ferring Pharmaceuticals Inc.
  18. Hao Hai Healthcare
  19. Bausch+Lomb
  20. Jingfeng
  21. Singclean Medical
  22. Hangzhou Gallop
  23. Changzhou Institute of Material Medical
  24. Bloomage Freda
  25. Henan Universe IOL
  26. EME

Global Hyaluronic Acid Solution Market Overview


Highlights of The Hyaluronic Acid Solution Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Single Injection
    2. Three Injection
    3. Five Injection
  1. By Application:

    1. Osteoarthritis
    2. Ophthalmic
    3. Dermal Fillers
    4. Vesicoureteral Reflux
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hyaluronic Acid Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hyaluronic Acid Solution Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Hyaluronic Acid Solution is a topical solution that contains hyaluronic acid. Hyaluronic acid is a natural substance found in the body and it helps keep skin hydrated. The solution can be used to treat dry skin, wrinkles, and age spots.

Some of the major companies in the hyaluronic acid solution market are Q-Med, Abbott Medical Optics, Seikagaku, Lipo Chemicals, Stanford Chemicals, Allergan, Novozymes, Anika Therapeutics, Hyaltech, LG LIFE & SCIENCE, Q-Med, Shiseido, Medicis Aesthetics Holdings, Inc, Synvisc-One, Genzyme Biosurgery, Merz Pharmaceuticals, Ferring Pharmaceuticals Inc., Hao Hai Healthcare, Bausch+Lomb, Jingfeng, Singclean Medical, Hangzhou Gallop, Changzhou Institute of Material Medical, Bloomage Freda, Henan Universe IOL, EME.

The hyaluronic acid solution market is expected to register a CAGR of 5.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyaluronic Acid Solution Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Hyaluronic Acid Solution Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Hyaluronic Acid Solution Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Hyaluronic Acid Solution Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Hyaluronic Acid Solution Market Size & Forecast, 2018-2028       4.5.1 Hyaluronic Acid Solution Market Size and Y-o-Y Growth       4.5.2 Hyaluronic Acid Solution Market Absolute $ Opportunity

Chapter 5 Global Hyaluronic Acid Solution Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Hyaluronic Acid Solution Market Size Forecast by Type
      5.2.1 Single Injection
      5.2.2 Three Injection
      5.2.3 Five Injection
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Hyaluronic Acid Solution Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Hyaluronic Acid Solution Market Size Forecast by Applications
      6.2.1 Osteoarthritis
      6.2.2 Ophthalmic
      6.2.3 Dermal Fillers
      6.2.4 Vesicoureteral Reflux
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Hyaluronic Acid Solution Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Hyaluronic Acid Solution Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Hyaluronic Acid Solution Analysis and Forecast
   9.1 Introduction
   9.2 North America Hyaluronic Acid Solution Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Hyaluronic Acid Solution Market Size Forecast by Type
      9.6.1 Single Injection
      9.6.2 Three Injection
      9.6.3 Five Injection
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Hyaluronic Acid Solution Market Size Forecast by Applications
      9.10.1 Osteoarthritis
      9.10.2 Ophthalmic
      9.10.3 Dermal Fillers
      9.10.4 Vesicoureteral Reflux
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Hyaluronic Acid Solution Analysis and Forecast
   10.1 Introduction
   10.2 Europe Hyaluronic Acid Solution Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Hyaluronic Acid Solution Market Size Forecast by Type
      10.6.1 Single Injection
      10.6.2 Three Injection
      10.6.3 Five Injection
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Hyaluronic Acid Solution Market Size Forecast by Applications
      10.10.1 Osteoarthritis
      10.10.2 Ophthalmic
      10.10.3 Dermal Fillers
      10.10.4 Vesicoureteral Reflux
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Hyaluronic Acid Solution Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Hyaluronic Acid Solution Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Hyaluronic Acid Solution Market Size Forecast by Type
      11.6.1 Single Injection
      11.6.2 Three Injection
      11.6.3 Five Injection
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Hyaluronic Acid Solution Market Size Forecast by Applications
      11.10.1 Osteoarthritis
      11.10.2 Ophthalmic
      11.10.3 Dermal Fillers
      11.10.4 Vesicoureteral Reflux
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Hyaluronic Acid Solution Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Hyaluronic Acid Solution Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Hyaluronic Acid Solution Market Size Forecast by Type
      12.6.1 Single Injection
      12.6.2 Three Injection
      12.6.3 Five Injection
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Hyaluronic Acid Solution Market Size Forecast by Applications
      12.10.1 Osteoarthritis
      12.10.2 Ophthalmic
      12.10.3 Dermal Fillers
      12.10.4 Vesicoureteral Reflux
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Hyaluronic Acid Solution Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Hyaluronic Acid Solution Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Hyaluronic Acid Solution Market Size Forecast by Type
      13.6.1 Single Injection
      13.6.2 Three Injection
      13.6.3 Five Injection
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Hyaluronic Acid Solution Market Size Forecast by Applications
      13.10.1 Osteoarthritis
      13.10.2 Ophthalmic
      13.10.3 Dermal Fillers
      13.10.4 Vesicoureteral Reflux
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Hyaluronic Acid Solution Market: Competitive Dashboard
   14.2 Global Hyaluronic Acid Solution Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Q-Med
      14.3.2 Abbott Medical Optics
      14.3.3 Seikagaku
      14.3.4 Lipo Chemicals
      14.3.5 Stanford Chemicals
      14.3.6 Allergan
      14.3.7 Novozymes
      14.3.8 Anika Therapeutics
      14.3.9 Hyaltech
      14.3.10 LG LIFE & SCIENCE
      14.3.11 Q-Med
      14.3.12 Shiseido
      14.3.13 Medicis Aesthetics Holdings, Inc
      14.3.14 Synvisc-One
      14.3.15 Genzyme Biosurgery
      14.3.16 Merz Pharmaceuticals
      14.3.17 Ferring Pharmaceuticals Inc.
      14.3.18 Hao Hai Healthcare
      14.3.19 Bausch+Lomb
      14.3.20 Jingfeng
      14.3.21 Singclean Medical
      14.3.22 Hangzhou Gallop
      14.3.23 Changzhou Institute of Material Medical
      14.3.24 Bloomage Freda
      14.3.25 Henan Universe IOL
      14.3.26 EME

Our Trusted Clients

Contact Us